CDH5 and plasma cell myeloma: Activation of endothelial ephrinB2 reverse signaling with soluble EphB2 or EphB2 overexpressing mouse myeloma cells showed a translocation of vascular endothelial cadherin (VE-cadherin) and enhanced endothelial permeability [19].